Logo image of NBVA.CA

NUBEVA TECHNOLOGIES LTD (NBVA.CA) Stock Fundamental Analysis

TSX-V:NBVA - TSX Venture Exchange - CA67021Y1097 - Common Stock - Currency: CAD

0.12  +0.02 (+20%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NBVA. NBVA was compared to 63 industry peers in the Software industry. While NBVA has a great health rating, there are worries on its profitability. NBVA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NBVA has reported negative net income.
NBVA had a positive operating cash flow in the past year.
In the past 5 years NBVA always reported negative net income.
In the past 5 years NBVA always reported negative operating cash flow.
NBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFNBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

NBVA has a Return On Assets (1.12%) which is in line with its industry peers.
NBVA's Return On Equity of 1.18% is in line compared to the rest of the industry. NBVA outperforms 57.14% of its industry peers.
Industry RankSector Rank
ROA 1.12%
ROE 1.18%
ROIC N/A
ROA(3y)-38.75%
ROA(5y)-61.47%
ROE(3y)-42.42%
ROE(5y)-87.72%
ROIC(3y)N/A
ROIC(5y)N/A
NBVA.CA Yearly ROA, ROE, ROICNBVA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

Looking at the Profit Margin, with a value of 6.09%, NBVA is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
The Operating Margin and Gross Margin are not available for NBVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 6.09%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NBVA.CA Yearly Profit, Operating, Gross MarginsNBVA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

8

2. Health

2.1 Basic Checks

NBVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NBVA has more shares outstanding
NBVA has more shares outstanding than it did 5 years ago.
NBVA has a worse debt/assets ratio than last year.
NBVA.CA Yearly Shares OutstandingNBVA.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NBVA.CA Yearly Total Debt VS Total AssetsNBVA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

An Altman-Z score of 15.10 indicates that NBVA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 15.10, NBVA belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
NBVA has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
NBVA's Debt to FCF ratio of 0.55 is amongst the best of the industry. NBVA outperforms 82.54% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NBVA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, NBVA belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.55
Altman-Z 15.1
ROIC/WACCN/A
WACC9.03%
NBVA.CA Yearly LT Debt VS Equity VS FCFNBVA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

NBVA has a Current Ratio of 21.26. This indicates that NBVA is financially healthy and has no problem in meeting its short term obligations.
NBVA's Current ratio of 21.26 is amongst the best of the industry. NBVA outperforms 96.83% of its industry peers.
A Quick Ratio of 21.26 indicates that NBVA has no problem at all paying its short term obligations.
NBVA has a better Quick ratio (21.26) than 96.83% of its industry peers.
Industry RankSector Rank
Current Ratio 21.26
Quick Ratio 21.26
NBVA.CA Yearly Current Assets VS Current LiabilitesNBVA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 105.94% over the past year.
The Revenue for NBVA has decreased by -74.89% in the past year. This is quite bad
The Revenue has been growing by 16.15% on average over the past years. This is quite good.
EPS 1Y (TTM)105.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
Revenue 1Y (TTM)-74.89%
Revenue growth 3Y-3.07%
Revenue growth 5Y16.15%
Sales Q2Q%-57.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBVA.CA Yearly Revenue VS EstimatesNBVA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
NBVA.CA Yearly EPS VS EstimatesNBVA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 -0.01 -0.02 -0.03 -0.04

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NBVA.CA Price Earnings VS Forward Price EarningsNBVA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

NBVA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 239.46
EV/EBITDA N/A
NBVA.CA Per share dataNBVA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NBVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUBEVA TECHNOLOGIES LTD

TSX-V:NBVA (6/13/2025, 7:00:00 PM)

0.12

+0.02 (+20%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-31 2025-03-31
Earnings (Next)08-26 2025-08-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.48%
Ins Owner ChangeN/A
Market Cap8.42M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.62
P/FCF 239.46
P/OCF 181.71
P/B 1.87
P/tB 1.87
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.42%
OCF(TTM)0
OCFY0.55%
SpS0.01
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 1.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.09%
GM N/A
FCFM 4.02%
ROA(3y)-38.75%
ROA(5y)-61.47%
ROE(3y)-42.42%
ROE(5y)-87.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.55
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 65.98%
Current Ratio 21.26
Quick Ratio 21.26
Altman-Z 15.1
F-Score6
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)305.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-74.89%
Revenue growth 3Y-3.07%
Revenue growth 5Y16.15%
Sales Q2Q%-57.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.64%
OCF growth 3YN/A
OCF growth 5YN/A